close
MENU
Investment
4 mins to read

FPH boss refuses to speculate on Trump tariffs

Listed respiratory health company F&P Healthcare employs nearly 1000 staff at its Mexico manufacturing facility.

US President-elect Donald Trump.

Key points
  • Revenue: Up 18% in the six months ended September 30 to $951.2 million.
  • Net profit after tax: Up 43% to $153.2m.
  • Main takeaway: The listed respiratory healthcare company will not be drawn on the potential impact of US tariffs on Mexico, where the company has a large manufacturing facility.

The boss of Fisher & Paykel Healthcare has refused to be drawn into any speculation on the possible impact of United States President-elect Donald Trump vowing to impose a 25% tariff on all products coming from Mexico.

The listed respiratory healthcare company today reported record half-year revenue

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Hamish McNicol Thu, 28 Nov 2024
Contact the Writer: Hmcnicol@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Key points
  • Revenue: Up 18% in the six months ended September 30 to $951.2 million.
  • Net profit after tax: Up 43% to $153.2m.
  • Main takeaway: The listed respiratory healthcare company will not be drawn on the potential impact of US tariffs on Mexico, where the company has a large manufacturing facility.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
FPH boss refuses to speculate on Trump tariffs
Investment,
106927
true